Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RUSSO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.248
EU - Europa 25.059
AS - Asia 21.264
SA - Sud America 3.380
AF - Africa 611
OC - Oceania 183
Continente sconosciuto - Info sul continente non disponibili 37
Totale 103.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.329
SG - Singapore 8.200
RU - Federazione Russa 6.882
CN - Cina 5.184
IT - Italia 4.556
FI - Finlandia 3.030
DE - Germania 2.906
BR - Brasile 2.679
HK - Hong Kong 2.027
VN - Vietnam 1.878
UA - Ucraina 1.415
PL - Polonia 1.296
GB - Regno Unito 1.199
FR - Francia 1.026
IE - Irlanda 809
JP - Giappone 733
BD - Bangladesh 660
SE - Svezia 585
IN - India 504
KR - Corea 499
CA - Canada 471
TR - Turchia 252
AR - Argentina 250
NL - Olanda 246
IQ - Iraq 239
RO - Romania 205
MX - Messico 204
BE - Belgio 188
AT - Austria 186
AU - Australia 171
ES - Italia 140
ZA - Sudafrica 127
PK - Pakistan 115
IR - Iran 114
EC - Ecuador 105
CI - Costa d'Avorio 102
UZ - Uzbekistan 99
MA - Marocco 89
MY - Malesia 85
VE - Venezuela 84
ID - Indonesia 77
CO - Colombia 71
PH - Filippine 67
KE - Kenya 64
EG - Egitto 62
SA - Arabia Saudita 62
CH - Svizzera 61
JM - Giamaica 59
CL - Cile 58
AE - Emirati Arabi Uniti 57
TN - Tunisia 49
PY - Paraguay 47
CZ - Repubblica Ceca 46
NP - Nepal 42
OM - Oman 42
LB - Libano 39
LT - Lituania 37
AZ - Azerbaigian 36
CR - Costa Rica 35
GR - Grecia 34
UY - Uruguay 33
IL - Israele 32
KZ - Kazakistan 32
BG - Bulgaria 30
DZ - Algeria 30
HN - Honduras 30
JO - Giordania 30
PE - Perù 29
PT - Portogallo 29
AL - Albania 26
DK - Danimarca 24
TW - Taiwan 24
EU - Europa 22
BO - Bolivia 20
DO - Repubblica Dominicana 20
TT - Trinidad e Tobago 18
NI - Nicaragua 16
RS - Serbia 16
BH - Bahrain 15
KG - Kirghizistan 15
ET - Etiopia 14
PA - Panama 14
PS - Palestinian Territory 14
TH - Thailandia 13
SN - Senegal 12
GE - Georgia 11
HU - Ungheria 11
MD - Moldavia 11
SV - El Salvador 11
SY - Repubblica araba siriana 11
BY - Bielorussia 9
MM - Myanmar 9
UG - Uganda 9
XK - ???statistics.table.value.countryCode.XK??? 9
NG - Nigeria 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
Totale 103.609
Salva come PNG Salva come JPEG
Città #
Fairfield 6.499
Ashburn 6.461
Singapore 5.130
Woodbridge 3.309
Chandler 2.824
San Jose 2.804
Houston 2.787
Wilmington 2.601
Seattle 2.552
Cambridge 2.127
Ann Arbor 1.950
Hong Kong 1.944
Moscow 1.167
Zgierz 1.091
Council Bluffs 959
Palermo 953
Beijing 846
Dublin 793
Helsinki 776
Medford 776
Los Angeles 729
Santa Clara 706
Jacksonville 700
Tokyo 680
New York 656
Ho Chi Minh City 602
Des Moines 590
Dallas 572
Altamura 536
Nanjing 535
Frankfurt am Main 526
Lauterbourg 509
The Dalles 499
Princeton 496
Hanoi 463
Boardman 422
Lawrence 419
San Diego 387
Hefei 368
Dearborn 334
Chicago 315
Rome 303
Buffalo 280
São Paulo 265
London 252
Phoenix 240
Ludwigshafen am Rhein 233
Tulsa 224
Milan 209
Munich 208
Brussels 182
Orem 181
Shenyang 171
Nanchang 153
Jinan 151
Seoul 148
Changsha 145
Atlanta 143
Nuremberg 141
Tianjin 137
Warsaw 134
Hebei 127
Seongnam 123
Columbus 114
Jiaxing 111
Guangzhou 105
Montreal 104
Abidjan 102
Brooklyn 99
Chennai 99
Denver 99
Bremen 94
Amsterdam 91
Falls Church 90
Da Nang 89
Izmir 88
Toronto 88
Kitzingen 87
Kumar 87
San Paolo di Civitate 87
Saint Petersburg 84
Baghdad 81
Venice 81
Zhengzhou 80
Stockholm 79
Johannesburg 77
Ningbo 77
Haiphong 73
Tashkent 71
Poplar 69
Redwood City 69
Lappeenranta 66
Rio de Janeiro 66
Shanghai 65
Vienna 65
Belo Horizonte 61
Tehran 59
Hangzhou 57
Mumbai 55
Salt Lake City 55
Totale 66.567
Salva come PNG Salva come JPEG
Nome #
S9-Fibronectin, EGF-R, HB-EGF:biomarkers of urothelial damage during intravesical adjuvant therapy? 614
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 416
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 377
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 365
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 354
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 347
EGFR inhibition in NSCLC: New findings…. and opened questions? 342
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 341
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 331
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 327
Dietary restriction: could it be considered as speed bump on tumor progression road? 326
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 326
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 325
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 325
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 325
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 320
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 319
Male breast cancer. 315
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 311
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 311
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 305
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 304
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 304
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 304
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 304
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 299
Founder mutations in BRCA1 and BRCA2 genes 299
Anti-endothelin drugs in solid tumors 299
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 295
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 294
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 293
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 293
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 292
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 290
Breast cancer genome-wide association studies: there is strength in numbers 289
A headlight on liquid biopsies: a challenging tool for breast cancer management 288
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 287
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 284
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 283
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 282
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 282
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 280
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 280
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 279
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 278
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 277
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 276
Update on capecitabine alone and in combination regimens in colorectal cancer patients 276
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 275
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 275
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 275
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 275
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells 274
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 272
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 272
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 272
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 272
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 272
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 270
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 269
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 268
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 268
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 267
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 267
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 267
The Clinical Significance of Unknown Sequence Variants in BRCA Genes 266
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 266
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 266
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 266
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 264
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 264
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 264
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. 263
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 263
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 262
Apoptosis: a relevant tool for anticancer therapy. 261
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 261
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 261
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 261
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 260
Targeted Therapies in Hepatocellular Carcinoma 260
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. 260
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 259
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 258
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 258
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 258
Nintedanib in NSCLC: Evidence to date and place in therapy 258
Emotional expression and coping style in female breast cancer. 257
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies:a meta-analysis(1988-2007) 257
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 257
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 256
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 255
Ductal lavage: a way of carefully tracing the breast-secreting duct 255
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 255
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 255
Role of S128R polymorphism of E-selectin in colon metastasis formation 255
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 254
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 254
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 253
Totale 28.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 358.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 358.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.708 388 1.381 240 251 292 278 409 357 658 769 615 1.070
2022/20238.818 900 1.694 158 919 931 1.208 494 630 1.322 66 349 147
2023/20243.879 181 517 267 327 276 745 480 323 45 119 55 544
2024/202511.674 218 767 732 880 447 493 989 1.209 781 1.309 1.568 2.281
2025/202638.433 2.969 1.209 2.334 2.941 3.814 5.563 5.298 3.835 3.012 4.184 1.619 1.655
2026/20271.246 1.246 0 0 0 0 0 0 0 0 0 0 0
Totale 106.570